Related Experiment Video
Updated: Aug 16, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Decoding m6A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance
Ying Cheng1, Zhuying Gao1, Tiantian Zhang1
1The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Medical Research Institute, Wuhan University, Wuhan, China; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Abstract:
N6-methyladenosine (m6A) is a common chemical modification for mammalian mRNA and exhibits high dynamics in various biological processes. However, dynamics of m6A RNA methylome during leukemogenesis remains unknown. Here, we delineate a comprehensive m6A landscape during acute myeloid leukemia (AML) development and identify PRMT6 as a key for maintaining AML stem cells. We observe an obvious change in m6A methylome during leukemogenesis and find that protein arginine methyltransferase PRMT6 and m6A reader IGF2BP2 maintain the function of human and murine leukemia stem cells (LSCs). Genetic deletion or pharmacological inhibition of PRMT6 damages AML development and LSC function. Mechanistically, IGF2BP2 stabilizes PRMT6 mRNA via m6A-mediated manner, which catalyzes H3R2me2a and suppresses lipid transporter MFSD2A expression. PRMT6 loss upregulates MFSD2A expression that increases docosahexaenoic acid levels and impairs LSC maintenance. Collectively, our findings reveal a critical role of PRMT6-MFSD2A signaling axis in AML development and provide a therapeutic strategy for targeting LSCs.
Insights
This study reveals how N6-methyladenosine (m6A) RNA modifications change during acute myeloid leukemia (AML) development. It identifies protein arginine methyltransferase 6 (PRMT6) as crucial for maintaining leukemia stem cells in AML.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- N6-methyladenosine (m6A) is a dynamic RNA modification involved in various biological processes.
- The role of the m6A RNA methylome in leukemogenesis is not well understood.
Purpose of the Study:
- To investigate the dynamics of the m6A methylome during acute myeloid leukemia (AML) development.
- To identify key molecular players, such as PRMT6, involved in maintaining leukemia stem cells (LSCs).
Main Methods:
- Comprehensive m6A landscape analysis during AML development.
- Genetic deletion and pharmacological inhibition of PRMT6 in human and murine models.
- Investigation of the mechanistic link between PRMT6, IGF2BP2, MFSD2A, and docosahexaenoic acid.
Main Results:
- Significant changes in the m6A methylome were observed during leukemogenesis.
- PRMT6 and the m6A reader IGF2BP2 were identified as critical for maintaining LSC function.
- Inhibition of PRMT6 impaired AML development and LSC function by upregulating MFSD2A expression and docosahexaenoic acid levels.
Conclusions:
- PRMT6 plays a vital role in AML development and LSC maintenance.
- The PRMT6-MFSD2A signaling axis represents a potential therapeutic target for AML.
More Related Videos
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
Related Concept Videos
RNA Stability
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...